Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis

Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cureus 2023, Vol.15 (12), p.e50050-e50050
Hauptverfasser: Ansari, Sahifah, Zamil, Dina H, Rodriguez, Edgar, Dunn, Carly, Kim, Soo Jung
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e50050
container_issue 12
container_start_page e50050
container_title Cureus
container_volume 15
creator Ansari, Sahifah
Zamil, Dina H
Rodriguez, Edgar
Dunn, Carly
Kim, Soo Jung
description Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity that presents similarly to SJS and is described here in a patient with increased risk due to his age, chronic kidney disease, and increased dose of methotrexate. His diagnosis was complicated by other historical risk factors, including antibiotic use, but was eventually elucidated when he was noted to have bone marrow suppression. Given the pathophysiology of SJS, a T-cell mediated reaction, the patient's leukopenia increased the likelihood of MEN as his ultimate diagnosis. However, in light of his aggressive treatment and non-specific histopathology, the clinical suspicion of MEN could not be confirmed.
doi_str_mv 10.7759/cureus.50050
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2911845566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2911845566</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_29118455663</originalsourceid><addsrcrecordid>eNqVjr0OAUEURidCQtB5gCk1uLPM7tKJnyjQ0Mtk3WXYnVlzZxKPT0KhVX3nJKf4GOsJGCaJnI6y4DDQUAJIqLFWJOJ0kIp0Uv_hJusS3QBAQBJBAi12XOo8R4fGa-W1ufAl0iOo8iOHuzZ8i6StoRmf84Ui5DbnO_RX6x0-lUe-qvQZXakKvsfMWdLUYY1cFYTd77ZZf706LjaDytlHQPKnUlOGRaEM2kCnaCre56SM4_Ef6QvqFkvB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2911845566</pqid></control><display><type>report</type><title>Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Ansari, Sahifah ; Zamil, Dina H ; Rodriguez, Edgar ; Dunn, Carly ; Kim, Soo Jung</creator><creatorcontrib>Ansari, Sahifah ; Zamil, Dina H ; Rodriguez, Edgar ; Dunn, Carly ; Kim, Soo Jung</creatorcontrib><description>Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity that presents similarly to SJS and is described here in a patient with increased risk due to his age, chronic kidney disease, and increased dose of methotrexate. His diagnosis was complicated by other historical risk factors, including antibiotic use, but was eventually elucidated when he was noted to have bone marrow suppression. Given the pathophysiology of SJS, a T-cell mediated reaction, the patient's leukopenia increased the likelihood of MEN as his ultimate diagnosis. However, in light of his aggressive treatment and non-specific histopathology, the clinical suspicion of MEN could not be confirmed.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.50050</identifier><language>eng</language><ispartof>Cureus, 2023, Vol.15 (12), p.e50050-e50050</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,4490,27925</link.rule.ids></links><search><creatorcontrib>Ansari, Sahifah</creatorcontrib><creatorcontrib>Zamil, Dina H</creatorcontrib><creatorcontrib>Rodriguez, Edgar</creatorcontrib><creatorcontrib>Dunn, Carly</creatorcontrib><creatorcontrib>Kim, Soo Jung</creatorcontrib><title>Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis</title><title>Cureus</title><description>Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity that presents similarly to SJS and is described here in a patient with increased risk due to his age, chronic kidney disease, and increased dose of methotrexate. His diagnosis was complicated by other historical risk factors, including antibiotic use, but was eventually elucidated when he was noted to have bone marrow suppression. Given the pathophysiology of SJS, a T-cell mediated reaction, the patient's leukopenia increased the likelihood of MEN as his ultimate diagnosis. However, in light of his aggressive treatment and non-specific histopathology, the clinical suspicion of MEN could not be confirmed.</description><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2023</creationdate><recordtype>report</recordtype><recordid>eNqVjr0OAUEURidCQtB5gCk1uLPM7tKJnyjQ0Mtk3WXYnVlzZxKPT0KhVX3nJKf4GOsJGCaJnI6y4DDQUAJIqLFWJOJ0kIp0Uv_hJusS3QBAQBJBAi12XOo8R4fGa-W1ufAl0iOo8iOHuzZ8i6StoRmf84Ui5DbnO_RX6x0-lUe-qvQZXakKvsfMWdLUYY1cFYTd77ZZf706LjaDytlHQPKnUlOGRaEM2kCnaCre56SM4_Ef6QvqFkvB</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Ansari, Sahifah</creator><creator>Zamil, Dina H</creator><creator>Rodriguez, Edgar</creator><creator>Dunn, Carly</creator><creator>Kim, Soo Jung</creator><scope>7X8</scope></search><sort><creationdate>20231201</creationdate><title>Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis</title><author>Ansari, Sahifah ; Zamil, Dina H ; Rodriguez, Edgar ; Dunn, Carly ; Kim, Soo Jung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_29118455663</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Ansari, Sahifah</creatorcontrib><creatorcontrib>Zamil, Dina H</creatorcontrib><creatorcontrib>Rodriguez, Edgar</creatorcontrib><creatorcontrib>Dunn, Carly</creatorcontrib><creatorcontrib>Kim, Soo Jung</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ansari, Sahifah</au><au>Zamil, Dina H</au><au>Rodriguez, Edgar</au><au>Dunn, Carly</au><au>Kim, Soo Jung</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis</atitle><jtitle>Cureus</jtitle><date>2023-12-01</date><risdate>2023</risdate><volume>15</volume><issue>12</issue><spage>e50050</spage><epage>e50050</epage><pages>e50050-e50050</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Desquamating skin lesions are a non-specific finding that requires urgent evaluation given the life-threatening severity of one of the potential causes, Stevens-Johnson syndrome (SJS). Methotrexate toxicity, also known in its cutaneous form as methotrexate epidermal necrosis (MEN), is another entity that presents similarly to SJS and is described here in a patient with increased risk due to his age, chronic kidney disease, and increased dose of methotrexate. His diagnosis was complicated by other historical risk factors, including antibiotic use, but was eventually elucidated when he was noted to have bone marrow suppression. Given the pathophysiology of SJS, a T-cell mediated reaction, the patient's leukopenia increased the likelihood of MEN as his ultimate diagnosis. However, in light of his aggressive treatment and non-specific histopathology, the clinical suspicion of MEN could not be confirmed.</abstract><doi>10.7759/cureus.50050</doi></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Cureus, 2023, Vol.15 (12), p.e50050-e50050
issn 2168-8184
2168-8184
language eng
recordid cdi_proquest_miscellaneous_2911845566
source PubMed Central Open Access; PubMed Central
title Differentiating Desquamating Skin Lesions: A Case of Methotrexate Epidermal Necrosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A34%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Differentiating%20Desquamating%20Skin%20Lesions:%20A%20Case%20of%20Methotrexate%20Epidermal%20Necrosis&rft.jtitle=Cureus&rft.au=Ansari,%20Sahifah&rft.date=2023-12-01&rft.volume=15&rft.issue=12&rft.spage=e50050&rft.epage=e50050&rft.pages=e50050-e50050&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.50050&rft_dat=%3Cproquest%3E2911845566%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2911845566&rft_id=info:pmid/&rfr_iscdi=true